OVH Groupe S.A. (OVHFF)

Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is September - August.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 24, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Market Capitalization	1,807	1,296	1,939	2,441	-	-
Market Cap Growth	-41.10%	-33.16%	-20.58%	-	-	-
Enterprise Value	3,184	2,175	2,555	2,890	-	-
Last Close Price	11.89	6.40	22.30	22.30	-	-
PS Ratio	1.67	1.18	1.99	3.08	-	-
PB Ratio	31.34	2.98	4.35	5.18	-	-
P/TBV Ratio	-	5.01	6.08	6.96	-	-
P/FCF Ratio	43.11	46.68	-	-	-	-
P/OCF Ratio	4.12	3.18	5.42	8.84	-	-
EV/Sales Ratio	2.64	1.98	2.63	3.64	-	-
EV/EBITDA Ratio	8.64	6.90	8.97	11.81	-	-
EV/EBIT Ratio	45.77	68.05	-	343.17	-	-
EV/FCF Ratio	75.96	78.32	-	-	-	-
Debt / Equity Ratio	23.45	2.19	1.91	1.29	7.22	5.54
Debt / EBITDA Ratio	4.07	2.71	2.72	2.33	3.18	2.64
Debt / FCF Ratio	32.25	34.32	-	-	-	-
Asset Turnover	0.60	0.61	0.59	0.59	0.57	0.65
Quick Ratio	0.44	0.39	0.39	0.41	0.44	0.55
Current Ratio	0.52	0.45	0.47	0.51	0.53	0.61
Return on Equity (ROE)	6.29%	-2.56%	-9.17%	-9.95%	-28.62%	-5.59%
Return on Assets (ROA)	2.18%	1.10%	-0.07%	0.39%	0.87%	2.52%
Return on Capital (ROIC)	2.91%	1.47%	-0.10%	0.54%	1.21%	3.36%
Return on Capital Employed (ROCE)	4.40%	2.30%	-	0.80%	1.90%	5.00%
Earnings Yield	0.81%	-0.88%	-2.25%	-1.18%	-	-
FCF Yield	2.32%	2.14%	-1.56%	-7.40%	-	-
Buyback Yield / Dilution	-3.84%	-7.26%	-0.86%	-11.82%	-5.40%	5.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.